Skip to main
  1. Stocks
  2. Addus HomeCare
  3. Forecast
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Addus HomeCare is viewed favorably because its core Personal Care business is showing improving same-store hours growth, better fill rates, and a shift toward higher-hour cases, which supports durable organic revenue expansion even in a challenging census environment. The company also has meaningful strategic upside from the pending $275MM AccentCare personal care acquisition, which is expected to add about $280MM in annualized revenue and deepen density in key states while leveraging Addus’s strong balance sheet, $98.5M of cash, and $617.8M of revolver availability. Fundamentally, the outlook is reinforced by steady Hospice reimbursement tailwinds, a Home Health inflection with 2.5% organic revenue growth and 13.8% new admissions growth, and EBITDA around $51.2M in 3Q with margins of 13.2%.

Bears say

Addus HomeCare is viewed negatively because its downside case assumes unforeseen rate headwinds in M&A execution and an inability to gain critical mass in additional key markets, which would limit its ability to benefit from managed care contracting opportunities. The outlook also points to a 15% haircut to FY27E EBITDA and a multiple compression to 9.0x, reflecting weaker earnings quality and a valuation more in line with primary home care. Further pressure could come from minimum wage increases without offsetting reimbursement, adverse pass-through reimbursement regulation, integration and compliance risks, and rising managed care penetration into government programs that could hurt revenue and profitability.

Addus HomeCare (ADUS) has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Addus HomeCare (ADUS) Analyst Forecast & Price Prediction

Get the latest Addus HomeCare (ADUS) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Addus HomeCare (ADUS)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 8 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Nov 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Addus HomeCare (ADUS) Analyst Forecast & Price Prediction

Get the latest Addus HomeCare (ADUS) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Addus HomeCare (ADUS)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover ADUS stock data and trends